MedPath

A study to determine if a new procedure(Thromboelastography guided blood product transfusion)can help in chronic liver disease patients undergoing invasive liver related procedures.

Not Applicable
Conditions
Health Condition 1: null- patients undergoing invasive liver related procedures in patients with chronic liver disease.
Registration Number
CTRI/2017/12/010822
Lead Sponsor
Department of Gastroenterology AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient undergoing invasive liver related procedures (eg, percutaneous liver biopsy, transjugular liver biopsy, transarterial chemoembolization, hepatic vein angioplasty/stenting, transjugular intrahepatic portosystemic shunt (TIPS)

2.Age between 18-65 years

3.Willing to participate in the study

Exclusion Criteria

1.Patients with malignancy/disseminated intravascular coagulation (DIC)/known coagulopathic disorder (haemophilia) apart from cirrhosis.

2.History of intake of platelets inhibitors (eg, aspirin, clopidogrel) and drugs affecting coagulation cascade (eg, vitamin K anatagonists) within past 7 days

3.Pregnant women and those on oral contraceptives

4.Patients with chronic renal failure

5.History of underlying hypercoagulable/ hypocoagulable states eg. paroxysmal nocturnal hemoglobunuria(PNH), polycythemiavera etc

6.Patients receiving blood products (fresh frozen plasma and platelet prior to thromboelastography)

7.Patients with shock

8.Sepsis

9.Not willing to provide consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath